Skip to content
★ Sign in to follow
HG

HARBIN GLORIA PHARMACEUTICALS Co., Ltd Stock: price and insider trades · China

誉衡药业

CN·Mcap CN¥7.3BHealth Care

HARBIN GLORIA PHARMACEUTICALS Co., Ltd: what insiders have been doing

HARBIN GLORIA PHARMACEUTICALS Co., Ltd is a Health Care company. Its directors and officers file their transactions with SSE / SZSE (CSRC). The past year has been quiet: not a single insider filing for HARBIN GLORIA PHARMACEUTICALS Co., Ltd. The previous disclosure was published on 1 July 2025.

Over the whole record (from 2025), the tally stands at no purchases and 2 sales.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.

Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€404,159
2 ops. · all time

Who traded when

BuySale
李润宝1 sale
王小航1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 5,189 of 26,897 companies
67.4
score / 100
Value
55
Quality
80
FCF yld3.7%
Earn yld5.7%
EV/EBITDA13.4x
ROE16%
Gross mgn45%
Net mgn18%
Debt/EBITDA0.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥3.26
Analyst consensus
·
Income statement
RevenueCN¥2.1B
Gross profitCN¥968.4M45% margin
EBITDACN¥502.9M24% margin
Net incomeCN¥376.9M19.7% margin
Valuation
PER (trailing)19.2x
P/Book2.9x
Beta0.16
Balance sheet & cash
Market capCN¥7.3B
Total debtCN¥92M
Free Cash FlowCN¥249.5M
Debt / Equity4%
Profitability & ownership
ROE17.9%
ROA5.0%
% insiders9.8%
% institutions10.2%
Last declaration on 1 July 2025
Declarations2 total
  • ▼
    高管Executives
    2M CNY31SZSE
    587,500 shares100.0% of flowA股XSHESZSE:173000009156850880
  • ▼
    高管Executives
    2M CNY31SZSE
    587,500 shares100.0% of flowA股XSHESZSE:173000009156850940

2 of 2 declarations

About HARBIN GLORIA PHARMACEUTICALS Co., Ltd

誉衡药业 is a company focused on the health and pharmaceutical sector, specializing in the development and manufacturing of medications. It is listed on the XSHE market.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations